Coronary artery bypass grafting (CABG) is the prevailing therapeutic procedure for treating ischemic heart disease. At our hospital, we perform off-pump coronary artery bypass grafting (OPCABG) without using an artificial heart-lung apparatus. This operative procedure enables us to cause less surgical stress to the patient and avoid complications induced by the apparatus. Our hospital is one of very few hospitals in the world with the sophistication of medical technology required to perform OPCABG. In cases where a patient has long stenotic lesions due to diabetes and other factors, the bypass cannot be constructed using normal methods. Instead of following this conventional surgical procedure, a longer coronary artery incision will be made. Next the hardened lesion will be removed and then the artery will be sutured together with a graft. This method, called “on-lay grafting,” was originally developed at our hospital by Dr. Shuichiro Takanashi.
Currently, the most common valvular replacement surgery in valvular disease is technically a safe and sure procedure due to its relative ease. However, patients with an artificial valve will need to continue to take medicine for the rest of their lives. Therefore, we choose to perform valvuloplasty requiring only 3 to 4 months of medication, despite the fact that the procedure itself is technically difficult. Furthermore, for adults over 85 years old who cannot undergo surgery, clinical research on an artificial valve apparatus using a catheter is in progress. Once this apparatus is developed, its application will greatly reduce surgical stress on the patient. Patients with severe congenital heart disease come to our hospital from all over the country, and we are one of the hospitals with the largest number of cardiovascular surgeries in Japan. Putting our priority on minimally invasive procedures such as surgeries without blood transfusions and shortening of anesthetic periods, we provide the most appropriate therapies, thanks to collaborative efforts among the pediatrics, surgery, and internal medicine departments.
|Average Number of Patients per Day Inpatients: 176 Outpatients: 289|
|Number of Surgeries||1,665 cases|
|Percutaneous Coronary Intervention (PCI)
As a cardiovascular specialty hospital, our hospital aims not only to save patients’ lives but also to improve their quality of life through treatment and therapy, especially by improving the rehabilitation rate. In order to achieve these goals, our clinical staff includes physicians and nurses with the highest training and experience, and we maintain a superior quality of medical healthcare. Because we believe that rehabilitation is essential for the patient to return to normal life, we provide high quality facilities and programs. We are especially proud of our organizational system, which brings our various departments together as a single team in order to treat patients with any type of cardiovascular disease. Flexible and smooth collaboration among all departments enables us to organize therapy planning and implement our plans. In other words, we can provide a carefully tailored treatment for each patient. As a result of this system, a patient who visits our hospital expecting to undergo surgery may, in some cases, be recommended to undergo percutaneous coronary intervention (coronary angioplasty), depending upon the test results. Since we treat cardiovascular disease in children and adults, an adult patient who underwent surgery for congenital heart disease at our hospital as a child can receive follow-up examinations in the departments of internal medicine as well as surgery. Our clinical team at Sakakibara Memorial Hospital has broad experience in CABG and percutaneous coronary intervention (coronary angioplasty) for ischemic heart disease, in valvuloplasty for valvular disorder in adults, and in congenital heart disease in children. Our hospital is one of the leading hospitals in Japan, and a large number of cardiovascular surgeries are performed on both adults and children. In fact, we were one of the hospitals that performed the largest number of cardiovascular surgeries in 2008.
Dr. Hitonobu Tomoike
One of our main principles is to “Practice medicine that meets the highest international standards.” We provide healthcare with pride as one of the leading cardiovascular specialty hospitals in Japan and the world. We work together as a team with the patient and strive to always provide the same high quality medical services to both our Japanese and foreign patients. We actively communicate with medical institutions, and have already admitted international patients for CABG and congenital heart disease surgery. In order to achieve our common global interest, “Live happy and live healthy,” we are committed to making our utmost efforts.
If a patient is admitted based on laboratory data conducted at an overseas medical institution, the waiting time will be short.
|External View of Our Hospital||Patient Room (Suite Room A)
The room is spacious and has been furnished in a living room style. This room is fully equipped with a small kitchen as well as a powder room and a bathroom. Each room has bedside computers installed so that patients can watch videos that show how tests and/or treatments are performed. Patients can also check their therapy schedule.
|Hospital Contact Information|
|Phone (for international visitors):
|Established 1977 (Relocated to Fuchu in 2003)|
Cardiovascular Internal Medicine, Cardiovascular Surgery, Cardiovascular Pediatrics, Radiology, Anesthesiology, Internal Medicine, Surgery, Pediatric, Cardiac Rehabilitation
Cash, Credit Card (Negotiable/Accepted upon Verification)
3-16-1 Asahi-cho, Fuchu-shi, Tokyo 183-0003
|Approximately 15 minutes on foot from
the Keio Line Tobitakyu Station
|Approximately 40 minutes from
Tokyo International Airport (Haneda Airport) by car
Patients wishing to use a helicopter are advised to call
Chofu Airport in Tokyo for inquiries and/or information.